Laia Crespo

Laia Crespo currently serves as a Partner at Sanofi Ventures since September 2018, holding board member positions in several biotech companies including Eligo Bioscience and Muna Therapeutics. Prior to this role, Laia Crespo was an Investment Director at Ysios Capital, where responsibilities included board membership for Minoryx and OxThera. Previous experience includes roles as an Investment Manager at Ysios Capital and a New Business Development Analyst at Johnson & Johnson. Laia Crespo's early career featured positions as a Research Scientist at UCB, Medivir AB, and Spirogen. Laia Crespo holds an MBA from the University of Cambridge and advanced degrees in Chemistry from Universitat de Barcelona, along with a Bachelor's degree in Piano and Music Theory from Liceu Music Conservatoire.